2,904 reported events
Top reactions: Lethargy (see also Central nervous system depression in Neurological) (486) · Vomiting (382) · Application site hair loss (275) · Hypersalivation (270) · Foaming at the mouth (243)
14 authorised products across national registers.
Canada — Health Canada DPD
Spain — CIMAVet (AEMPS)
France — ANSES-ANMV
United Kingdom — VMD
United States — FDA Green Book
Australia — APVMA PUBCRIS
No residue limits (MRL) are recorded for this substance.
No antimicrobial-resistance surveillance is recorded for this substance.
Spontaneous adverse-event reports that name Esafoxolaner, by species — reported counts, not proven reactions.
Top reactions: Lethargy (see also Central nervous system depression in Neurological) (486) · Vomiting (382) · Application site hair loss (275) · Hypersalivation (270) · Foaming at the mouth (243)
Source: openFDA Animal & Veterinary adverse-event reports.
Reading about Esafoxolaner? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.
Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.